Aplysianin P
Latest Information Update: 08 Feb 2001
At a glance
- Originator Kanagawa University; Kitasato University; Teikyo University
- Class Antibacterials; Antineoplastics; Glycopeptides
- Mechanism of Action DNA synthesis inhibitors; RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 08 Feb 2001 Profile reviewed but no significant changes made
- 22 Oct 1997 No-Development-Reported for Cancer in Japan (Unknown route)
- 02 Apr 1990 Preclinical development for Cancer in Japan (Unknown route)